Key result
Acute myocardial infarction is linked to ~23 days of lost life expectancy over 3 years.
Why the study?
The mortality risk of acute myocardial infarction declines rapidly after the initial period, yet quantitative measures of residual risk during follow-up remain limited.
Cohort (n=27,705)
Yes
Patients with acute myocardial infarction experience an overall 3-year restricted loss of life expectancy of 23 days compared to the matched general population, with higher losses in older, female, and low-LVEF subgroups, though overall outcomes improved significantly between 2012 and 2020.
Answers are grounded in this paper and cite their sources.
Quantifies modest residual life expectancy loss post-AMI for counseling; extends registry insights on temporal trends but leaves open targeted interventions.
Background The mortality risk of acute myocardial infarction (AMI) declines rapidly after the initial period, yet the quantitative measures of residual risk in the follow-up period remain limited. Purpose We aimed to assess restricted loss of life expectancy (LOLE) in patients with AMI. Methods We included patients from KAMIR, a nationwide AMI registry, between 2012 and 2020. The survival of 27,705 patients (mean age 64 years, 76% male) was compared with an age-, sex-, and calendar year-matched reference cohort derived from Korean population life tables. Three-year restricted LOLE was estimated using Royston-Parmar flexible parametric survival model adjusted for clinical characteristics. Results In overall, 3-year restricted LOLE was 23 days (95%CI = 22 – 25 days). In subgroup analyses, older age (≥75 years, 41 [37 – 46] days versus <50 years, 7 [6 –13] days), female sex (48 [44 – 52] days versus male, 15 [14 – 17] days), and lower left ventricular ejection fraction (≤40%, 135 [128 – 143] days versus ≥50%, 0 [-1 – 1] days) were associated with higher 3-year restricted LOLE. Across the study period, 3-year restricted LOLE nearly halved from 36 [33 – 42] to 16 [13 – 28] days. Conclusions Restricted LOLE provides intuitive, patient-centered measures of residual risk after AMI. It also demonstrated a significant improvements in patient outcomes over the study period.
No takes yet. Share an insight, caveat, or question.
Choi et al. (2026) conducted a cohort in Acute myocardial infarction (AMI) (n=27,705). Acute myocardial infarction (AMI) vs. Age-, sex-, and calendar year-matched reference cohort from Korean population life tables was evaluated on 3-year restricted loss of life expectancy (LOLE) (23 days, 95% CI 22-25). Acute myocardial infarction was associated with an overall 3-year restricted loss of life expectancy of 23 days compared with a matched general population cohort.
Synapse has enriched 10 related papers. Consider them for comparative context: